论文部分内容阅读
CS1206-A phase ib dose-escalating study to evaluate the safety, tolerability, pharmacokinetics and p
【作 者】
：
【机 构】
：
Merck-Serono International,Geneva,Switzerland GU
【出 处】
：
The 8th International Congress on SLE(第八届国际红斑狼疮学术会议)
【发表日期】
：
2007年12期
其他文献
CS0906-Exploiting innate immunity to control autoimmunity:iNKT cells suppress autoantibody-producing
会议
CS1101-Response to inducible nitric oxide synthase inhibitor in a murine lupus model deficient in in
会议
CS1108-invited talk Production of type Ⅰ interferon by circulating monocyte-like cells with deficien
会议
CS1109-invited talk A new etiology of autoimmune diseases:aberrant microRNA-mediated regulation of I
会议
CS1201-Protocol design for the EXPLORER study of the efficacy and safety of rituximab in patients wi
会议
CS1202 Novel Combined Response Endpoint Shows that Belimumab (Fully Human Monoclonal Antibody to B-L
会议